Selah Technologies CEO to Serve on Advisory Board of the Rutland Institute for Ethics

Selah Technologies, an advanced materials manufacturer, announced today that Michael Bolick, the company's founder and CEO, has been appointed to serve on the Advisory Board of the Robert J. Rutland Institute of Ethics at Clemson University.

“I am honored to serve on the Advisory Board of the Rutland Institute for Ethics. The mission and outreach of the Rutland Institute are an ideal venue to expound to the students, the faculty and the community the importance of taking personal responsibility for their actions and to instill that integrity, fairness and compassion are essential components of any decision-making process. The importance of making moral and ethical choices in life, as in business, cannot be overlooked or overstated,” said Michael Bolick, President and CEO for Selah.

Selah Technologies obtained a worldwide exclusive license in 2006 from Clemson University to develop and commercialize two nanotechnologies, branded Selah Dots™ and Selah Tubes™. Selah Dots™ are patent-pending brightly luminescent carbon based nanoparticles that can be used for various applications, including life sciences, solar cells and anti-counterfeiting, among others. Selah Tubes™, enriched carbon nanotubes protected under US Patent No. 7,374,685, have a number of applications due to their impressive electrical and thermal conductivity properties.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.